These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 5137311)

  • 1. Inhibition of HIPA plasmacytoma cell-free transmission by normal spleen of BALB-c, DBA-2 and C3H mice.
    Pedio G; Rüttner JR
    Int J Cancer; 1971 Nov; 8(3):497-502. PubMed ID: 5137311
    [No Abstract]   [Full Text] [Related]  

  • 2. Loss of protective activity of BALB-c spleen homogenate against cell-free transmission of HIPA-plasmacytoma by pretreatment with mineral oil of spleen-donor mice.
    Pedio G; Rüttner JR; Odermatt BF
    Pathol Microbiol (Basel); 1972; 38(5):375-8. PubMed ID: 4648589
    [No Abstract]   [Full Text] [Related]  

  • 3. Evaluation of monodansylcadaverine for effects on tumor growth.
    Yancey ST; Laki K
    J Natl Cancer Inst; 1974 Mar; 52(3):733-5. PubMed ID: 4826562
    [No Abstract]   [Full Text] [Related]  

  • 4. Tumor immunity to murine plasma cell tumors. III. Detection of common and unique tumor-associated antigens on BALB/c, C3H, and NZB plasmacytomas by in vivo and in vitro induction of tumor-immune responses.
    Burton RC; Warner NL
    J Natl Cancer Inst; 1977 Mar; 58(3):701-9. PubMed ID: 300112
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preliminary observations on immunity in BALB-c mice to myeloma tumor of BALB-c origin.
    Shearer WT; Graff RJ; Eisen HN
    Transplantation; 1972 Mar; 13(3):345-7. PubMed ID: 5021442
    [No Abstract]   [Full Text] [Related]  

  • 6. Passive immunity to murine plasmacytoma by rabbit antiidiotypic antibody to myeloma protein.
    Chen Y; Yakulis V; Heller P
    Proc Soc Exp Biol Med; 1976 Jan; 151(1):121-5. PubMed ID: 1250837
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alteration of cell-surface antigenicity of the mouse plasmacytoma. II. Lack of correlation between synthesis of myeloma protein and alteration of surface antigen.
    Ohno S; Natsu-ume-Sakai S; Migita S
    J Natl Cancer Inst; 1977 Feb; 58(2):229-37. PubMed ID: 833874
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suppression of in vivo growth of mouse myelomas by purified rabbit antibodies against mouse myeloma cells.
    Yutoku M; Grossberg AL; Pressman D
    J Natl Cancer Inst; 1974 Jul; 53(1):201-7. PubMed ID: 4835105
    [No Abstract]   [Full Text] [Related]  

  • 9. Blocking effect of the migration-inhibition reaction by sera from immunized syngeneic mice and by sera from plasmacytoma-bearing BALB-c mice. Detection of free, circulating tumor antigen.
    Poupon MF; Lespinats G; Kolb JP
    J Natl Cancer Inst; 1974 Apr; 52(4):1127-34. PubMed ID: 4826584
    [No Abstract]   [Full Text] [Related]  

  • 10. [On the oncogenesia of plasmacytoma (LPC-1). Transplantable neoplasm (HIPA) with plasma cell evolution, induced by spleen homogenate from a BALB-c mouse treated with mineral oil. 1. Biology and histology].
    Pedio G; Grieshaber E; Rüttner JR
    Pathol Microbiol (Basel); 1968; 31(5):278-86. PubMed ID: 5687787
    [No Abstract]   [Full Text] [Related]  

  • 11. The allogeneic effect on tumor growth. I. Inhibition of a murine plasmacytoma, MOPC 315, by the graft-vs-host reaction.
    Osborne DP; Katz DH
    J Immunol; 1977 Apr; 118(4):1441-8. PubMed ID: 15034
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of immune responses aginst the syngeneic ADJ-PC-5 plasmacytoma in BALB-c mice. III. Induction of specific T suppressor cells to the BALB/c plasmacytoma ADJ-PC-5 during early stages of tumorigenesis.
    Haubeck HD; Kölsch E
    Immunology; 1982 Nov; 47(3):503-10. PubMed ID: 6215340
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The allogeneic effect on tumor growth. II. Suppression of both ascitic and solid MOPC 315 plasmacytoma by the graft-vs-host reaction, with pathologic correlation.
    Osborne DP; Katz DH
    J Immunol; 1977 Apr; 118(4):1449-55. PubMed ID: 15035
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumour immunoprophylaxis in mice using glutaraldehyde-treated syngeneic myeloma cells.
    Ben-Efraim S; Ophir R; Relyveld EH
    Br J Cancer; 1981 Apr; 43(4):554-7. PubMed ID: 6786316
    [No Abstract]   [Full Text] [Related]  

  • 15. Brief communication: In vivo protection against murine plasma cell tumor growth by in vitro activated syngeneic lymphocytes.
    Röllinghoff M; Wagner H
    J Natl Cancer Inst; 1973 Oct; 51(4):1317-8. PubMed ID: 4745860
    [No Abstract]   [Full Text] [Related]  

  • 16. [The influence of sex, pregnancy and age of the incidence of the HIPA-plasmocytoma of the BALB-c-mice after cellfree tumor transmission (author's transl)].
    Zünd T; Odermatt B; Pedio G; Rüttner J
    Virchows Arch B Cell Pathol; 1973 Dec; 14(3):215-22. PubMed ID: 4203890
    [No Abstract]   [Full Text] [Related]  

  • 17. Tumor-associated immunosuppressive factors.
    Friedman H; Secter S; Kamo I; Kateley J
    Ann N Y Acad Sci; 1976; 276():417-30. PubMed ID: 829207
    [No Abstract]   [Full Text] [Related]  

  • 18. Cellular and viral antigens of BALB-c myeloma.
    Krueger RG; Williams WH; Miller GC
    J Natl Cancer Inst; 1974 Apr; 52(4):1203-10. PubMed ID: 4133200
    [No Abstract]   [Full Text] [Related]  

  • 19. Tumor immunity to murine plasma cell tumors. I. Tumor-associated transplantation antigens of NZB and BALB-c plasma cell tumors.
    Röllinghoff M; Rouse BT; Warner NL
    J Natl Cancer Inst; 1973 Jan; 50(1):159-72. PubMed ID: 4571237
    [No Abstract]   [Full Text] [Related]  

  • 20. Idiotype-binding cells in plasmacytoma-bearing mice.
    Serban D; Ran M; Witz IP
    Cell Immunol; 1979 Apr; 44(1):1-8. PubMed ID: 313254
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.